Related Experiment Video
Updated: Jun 2, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Expression of CD44 spliced variants with both exons v9 and v10 in primary N(-)M(-) breast carcinomas correlates with
N Guriec1, B Gairard, L Marcellin
1UNIV HOSP,INST RECH HEMATOL,F-67000 STRASBOURG,FRANCE. UNIV HOSP,DEPT GYNAECOL,F-67000 STRASBOURG,FRANCE. UNIV HOSP,DEPT STOMATOL & PLAST SURG,F-67000 STRASBOURG,FRANCE. UNIV HOSP,DEPT ONCOL,F-67000 STRASBOURG,FRANCE. UNIV HOSP,DEPT ANATOMOPATHOL,F-67000 STRASBOURG,FRANCE. UNIV HOSP,DEPT SURG ONCOL,F-67000 STRASBOURG,FRANCE.
Abstract:
We analyzed the representation of CD44 isoforms with both exons v9 and v10 among CD44 total amount and also examined correlation between their expression, clinical parameters and survival. We used a semi-quantitative RT-PCR reaction and a panel of 25 normal breast specimens, 10 mammary fibroadenomas, 8 cystic samples and 52 primary breast tumors. CD44 expression level was statistically higher in malignant tumors than in normal breast tissues (p = 0.038) or in fibroadenomas (p = 0.047) and correlated with histological grading, p = 0.047. Ratios CD44 variants with both exons v9 and v10/ total CD44 were similar in normal breast tissues and fibroadenomas but lower in the cystic samples. In primary N(-)M(-) breast tumors, unfavourable outcome and relapse were correlated with low ratios.
Related Concept Videos
RNA Splicing
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
